Clinical trials and operational research studies to optimise the use of products for poverty-related diseases in mothers, newborns, children and/or adolescents
This call aims to support actions on preventive and therapeutic clinical interventions of post-registration products, as well as related behavioural studies, aimed at optimising use of new or improved products or combination of products for mothers, newborns, children and/or adolescents.
The scope of this call is limited to clinical trials and operational studies with a product focus.
Activities may include: studies on product (drugs, vaccines, microbicides and diagnostics) development, delivery, uptake and adherence; and strategies for equitable and full-scale access to diagnostics, prevention and treatment interventions. This includes community-based interventions/approaches and qualitative studies.
Call budget: € 10M
Maximum funding: € 3M
Funding level: 100% of eligible costs
Stage 1 (Letter of Intent)
Open date: 7 July 2016
Close date: 29 September 2016
Stage 2 (Full proposal)
Open date (indicative): 12 December 2016
Close date (indicative): 2 March 2017
Go to full call description